Handelsbanken Fonder’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18,500
| Closed | -$756K | – | 1534 |
|
|
2024
Q2 | $756K | Buy |
18,500
+2,300
| +14% | +$94K | ﹤0.01% | 963 |
|
|
2024
Q1 | $685K | Hold |
16,200
| – | – | ﹤0.01% | 1015 |
|
|
2023
Q4 | $687K | Buy |
16,200
+4,600
| +40% | +$195K | ﹤0.01% | 968 |
|
|
2023
Q3 | $253K | Hold |
11,600
| – | – | ﹤0.01% | 1372 |
|
|
2023
Q2 | $369K | Buy |
11,600
+2,600
| +29% | +$82.7K | ﹤0.01% | 1238 |
|
|
2023
Q1 | $220K | Hold |
9,000
| – | – | ﹤0.01% | 1426 |
|
|
2022
Q4 | $284K | Hold |
9,000
| – | – | ﹤0.01% | 1281 |
|
|
2022
Q3 | $254K | Buy |
9,000
+300
| +3% | +$8.47K | ﹤0.01% | 1338 |
|
|
2022
Q2 | $230K | Sell |
8,700
-1,600
| -16% | -$42.3K | ﹤0.01% | 1450 |
|
|
2022
Q1 | $361K | Hold |
10,300
| – | – | ﹤0.01% | 1411 |
|
|
2021
Q4 | $334K | Buy |
+10,300
| New | +$334K | ﹤0.01% | 1577 |
|